Literature DB >> 17056307

Fetoscopic surgery: encouraged by clinical experience and boosted by instrument innovation.

Jan Deprest1, Jacques Jani, Liesbeth Lewi, Nicole Ochsenbein-Kölble, Mieke Cannie, Elisa Doné, Xenia Roubliova, Tim Van Mieghem, Anne Debeer, Frederik Debuck, Laurenço Sbragia, Jaan Toelen, Roland Devlieger, Paul Lewi, Marc Van de Velde.   

Abstract

Today, modern ultrasound equipment and the wide implementation of screening programmes allow the timely diagnosis of many congenital anomalies. For some of these, fetal surgery may be a life-saving option. In Europe, open fetal surgery became poorly accepted because of its invasiveness and the high incidence of postoperative premature labour and rupture of the fetal membranes. In the 1990s, the merger of fetoscopy and advanced video-endoscopic surgery formed the basis for endoscopic fetal surgery. We review the current applications of fetal surgery via both methods of access. The first clinical fetoscopic surgeries were interventions on the umbilical cord and the placenta, often referred to as obstetrical endoscopy. The outcome of a randomized clinical trial demonstrating that fetoscopic laser coagulation of chorionic plate vessels is the most effective treatment for twin-twin transfusion syndrome (TTTS) has revived interest in endoscopic fetal therapy. Operating on the fetus is another more challenging enterprise. Clinical fetal surgery programmes were virtually non-existent in Europe until minimally invasive fetoscopic surgery made such operations clinically possible as well as maternally acceptable. At present, most experience has been gathered with fetal tracheal occlusion as a therapy for severe congenital diaphragmatic hernia. As in other fields, minimally invasive surgery has pushed back boundaries and now allows safe operations to be performed on the fetal patient. Whereas minimal access seems to solve the problem of preterm labour, all procedures remain invasive, and carry a risk to the mother and a substantial risk of preterm prelabour rupture of the membranes (PPROM). The latter problem may prove to be a bottleneck for further developments, although treatment modalities are currently being evaluated.

Entities:  

Mesh:

Year:  2006        PMID: 17056307     DOI: 10.1016/j.siny.2006.09.003

Source DB:  PubMed          Journal:  Semin Fetal Neonatal Med        ISSN: 1744-165X            Impact factor:   3.926


  8 in total

1.  The art of fetoscopy: a step toward minimally invasive fetal therapy.

Authors:  Dipika Deka; Vatsla Dadhwal; S B Gajatheepan; Aprajita Singh; K Aparna Sharma; Neena Malhotra
Journal:  J Obstet Gynaecol India       Date:  2012-08-17

Review 2.  Advances in fetal surgery.

Authors:  Kathryn M Maselli; Andrea Badillo
Journal:  Ann Transl Med       Date:  2016-10

Review 3.  Sealing procedures for preterm prelabour rupture of membranes.

Authors:  Adele E Crowley; Rosalie M Grivell; Jodie M Dodd
Journal:  Cochrane Database Syst Rev       Date:  2016-07-07

4.  [Development of pediatric surgery in the next 20 years].

Authors:  W Barthlen
Journal:  Chirurg       Date:  2009-12       Impact factor: 0.955

Review 5.  Congenital diaphragmatic hernia: current status and review of the literature.

Authors:  Anthony S de Buys Roessingh; Anh Tuan Dinh-Xuan
Journal:  Eur J Pediatr       Date:  2008-12-23       Impact factor: 3.183

Review 6.  The fetal respiratory system as target for antenatal therapy.

Authors:  J Toelen; M Carlon; F Claus; R Gijsbers; I Sandaite; K Dierickx; R Devlieger; K Devriendt; A Debeer; M Proesmans; Z Debyser; A J Deprest
Journal:  Facts Views Vis Obgyn       Date:  2011

7.  The fetal patient -- ethical aspects of fetal therapy.

Authors:  J Deprest; J Toelen; Z Debyser; C Rodrigues; R Devlieger; L De Catte; L Lewi; T Van Mieghem; G Naulaers; M Vandevelde; F Claus; K Dierickx
Journal:  Facts Views Vis Obgyn       Date:  2011

8.  Magnetic resonance imaging of the fetal lung: a pictorial essay.

Authors:  M Cannie; J Jani; F De Keyzer; F Van Kerkhove; J Meersschaert; L Lewi; J Deprest; S Dymarkowski
Journal:  Eur Radiol       Date:  2008-02-13       Impact factor: 7.034

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.